Kim Aardalen

Company: Odyssey Therapeutics

Job title: Director, Preclinical Pharmacology Oncology

Seminars:

Mouse Models (CDX, PDX & More) 4:45 pm

• Reviewing the reasons and context for use • Spotlighting methods to optimize translatability to patients • Determining analysis strategies for combination efficacy and safetyRead more

day: Day One Track A PM 2

Fireside Chat: The Future of Preclinical Tumor Models 2:45 pm

• How can we use preclinical models to streamline drug development and make it more cost-effective? • Highlighting the importance of optimizing translatability into the clinic – the next steps • How can models be used in the context of precision oncology? Moderated by: Katie Grausam, Postdoctural Scientist, Cedards-Sinai Medical CenterRead more

day: Day Two